Skip to main content
. 2022 Jun 13;37(1):189–199. doi: 10.1007/s10877-022-00878-2

Table 3.

Hemodynamic support types and blood transfusion characteristics

POD Support type Support level, % (N)
Low (0) Medium (1–2) High ( 3)
0 Vasoactive drugs
Inotropes 35.0% (48) 62.8% (86) 2.2% (3)
Vasopressors 0.7% (1) 83.9% (115) 15.3% (21)
Blood products
Cryoprecipitate (bags) 92.7% (127) 5.1% (7) 2.2% (3)
FFP (bags) 91.2% (125) 4.4% (6) 4.4% (6)
Platelets (bags) 73.0% (100) 14.6% (20) 12.4% (17)
pRBC (bags) 78.1% (107) 8.0% (11) 13.9% (19)
1 Vasoactive drugs
Inotropes 55.5% (76) 44.5% (61) 0
Vasopressors 41.6% (57) 56.2% (77) 2.2% (3)
Blood products
Cryoprecipitate (bags) 97.8% (134) 1.5% (2) 0.7% (1)
FFP (bags) 97.8% (134) 1.5% (2) 0.7% (1)
Platelets (bags) 94.9% (130) 2.2% (3) 2.9% (4)
pRBC (bags) 84.7% (116) 6.6% (9) 8.8% (12)

Values are represented as in % or absolute numbers in parenthesis. Low (0), Medium (1–2) or High ( 3) support of vasoactive drugs represent the number of inotropes of vasopressors that patients were receiving. Inotropes represent Dobutamine, Milrinone, Epinephrine, Dopamine. Vasopressors represent Norepinephrine, Vasopressin, Phenylephrine, Angiotensin II

POD postoperative day; CABG cardiopulmonary bypass graft; FFP fresh frozen plasma; pRBC packed red blood cells